Keywords: آنتاگونیست اپوئیدی; Opiate dependence treatment; Pharmacotherapy trials; Injection naltrexone; Oral naltrexone; Opioid antagonist
مقالات ISI آنتاگونیست اپوئیدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتاگونیست اپوئیدی; Addiction; Detoxification; Pharmacotherapy; Opioid agonist; Opioid antagonist; Minority recruitment;
Keywords: آنتاگونیست اپوئیدی; Long-acting injectable naltrexone; Opiate dependence; Opioid antagonist; Treatment retention; Urine toxicology;
Keywords: آنتاگونیست اپوئیدی; Naltrexone; nicotine dependence; opioid antagonist; sex differences; smoking cessation; weight gain;
Keywords: آنتاگونیست اپوئیدی; Alcohol dependence; Harm-reduction; Nalmefene; Opioid antagonist; As-needed; Treatment;
Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours
Keywords: آنتاگونیست اپوئیدی; Opioid antagonist; Leydig cell tumour; Testis; Luteinizing hormone; Testosterone;
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
Keywords: آنتاگونیست اپوئیدی; Botulinum toxin A; Opioid antagonist; μ-Opioid receptors; Formalin test; Peripheral neuropathy; c-Fos; BTX-A; botulinum toxin type A; SNAP-25; Synaptosomal Associated Protein of 25 kDa; i.pl.; intraplantarly; s.c.; subcutaneously; i.t.; intrathecally; i
Evaluation of the Effect of Naloxegol on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT/QTc Study in Healthy Volunteers
Keywords: آنتاگونیست اپوئیدی; cardiac repolarization; electrocardiography; naloxegol; opioid antagonist; opioid-induced constipation; peripheral µ-opioid receptor antagonist;
Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
Keywords: آنتاگونیست اپوئیدی; Alcohol dependence; as-needed; nalmefene; opioid antagonist; placebo-controlled; reduction
Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits
Keywords: آنتاگونیست اپوئیدی; Opioid antagonist; Opioid receptors; G-protein; Adenylyl cyclase; Constitutive activity; Inverse agonismAC, Adenylyl cyclase; DAMGO, Tyr-d-Ala-Gly-Me-Fe-Gly-ol-enkephalin; FK, Forskolin; ODN, oligodeoxyribonucleotides; PTX, Pertussis toxin
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols – Carbocyclic relatives of f-oxide-bridged phenylmorphans
Keywords: آنتاگونیست اپوئیدی; Synthesis; Opioid receptor binding and efficacy; N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols; f-Oxide-bridged phenylmorphans; Opioid antagonist
Pruritus in Chronic Cholestatic Liver Disease
Keywords: آنتاگونیست اپوئیدی; Pruritus; Itching; Cholestasis; Liver disease; Pathogenesis; Management; Opioid antagonist; Cholestyramine;
Differential effects of chronic naltrexone treatment on food intake patterns and body weight in rats depend on their food deprivation status
Keywords: آنتاگونیست اپوئیدی; Naltrexone; Food intake; Body weight; Water consumption; Opioid antagonist; Alimentary behaviour
Naloxone in cardiac arrest with suspected opioid overdoses
Keywords: آنتاگونیست اپوئیدی; Naloxone; Opioid antagonist; Overdose; Cardiac arrest; Antiarrhythmic
In vivo characterization of the opioid antagonist nalmefene in mice
Keywords: آنتاگونیست اپوئیدی; Opioid antagonist; Pain; Antinociception; Mu opioid receptor;
Naltrexone fails to increase pain affect in response to inflammatory pain in a novel escape/avoidance paradigm
Keywords: آنتاگونیست اپوئیدی; Naltrexone; Carrageenan; Inflammatory pain; Naloxone; Place Escape Avoidance Paradigm; Opioid antagonist; Morphine; MPWT; Mechanical hypersensitivity
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats
Keywords: آنتاگونیست اپوئیدی; naltrexone; insulin; diabetes; cornea; wound healing; opioid antagonist;
6β-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice
Keywords: آنتاگونیست اپوئیدی; Opioid antagonist; Naltrexone; 6β-naltrexol; Hydrocodone; Gastrointestinal transit
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Keywords: آنتاگونیست اپوئیدی; Obsessive–compulsive disorder; Naltrexone; Addiction; Opioid antagonist; Augmentation
Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice
Keywords: آنتاگونیست اپوئیدی; Naltrexone; Opioid antagonist; Neuroprotection; Bcl-2 family; Fas signalling; Apoptosis;
μ- but not δ- and κ-opioid receptor mediates the nucleus submedius interferon-α-evoked antinociception in the rat
Keywords: آنتاگونیست اپوئیدی; Interferon-alpha; Thalamic nucleus submedius; Antinociception; Opioid receptor; Opioid antagonist
Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1-7
Keywords: آنتاگونیست اپوئیدی; Inflammation; Nerve injury; Opioid antagonist; Substance P (SP); Substance P fragments SP1-7, SP5-11 and SP9-11; Rats; Vasodilatation;
The ethanol self-administration context as a reinstatement cue: Acute effects of naltrexone
Keywords: آنتاگونیست اپوئیدی; relapse; alcohol addiction; opioid; opioid antagonist; rat; FR; fixed ratio; VTA; ventral tegmental area; v/v; volume/volume; w/v; weight/volume; 10E; 10% ethanol;
SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists
Keywords: آنتاگونیست اپوئیدی; Opioid antagonist; trans-3,4-Dimethyl-4-arylpiperidine
[3H]Alvimopan binding to the μ opioid receptor: Comparative binding kinetics of opioid antagonists
Keywords: آنتاگونیست اپوئیدی; Alvimopan; N-methylnaltrexone; Opioid receptor; Opioid antagonist; Kinetics;